Investors



SEC Filings

Filing date Form Description Filing Group View
CT ORDER

CT ORDER

Other
View HTML
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
View HTML
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
View HTML
SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

3,4,5
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

3,4,5
View HTML
424B4

Form of prospectus disclosing information facts events covered in both forms 424B1 424B3

Registration Statements
View HTML
EFFECT

EFFECT

Other
View HTML
F-1/A

This filing is a pre-effective amendment to an F-1 filing

Registration Statements
View HTML
CERTNAS

CERTNAS

Other
View HTML
F-1/A

This filing is a pre-effective amendment to an F-1 filing

Registration Statements
View HTML

Copyright Morningstar







© 2019 Strongbridge Biopharma plc
STRONGBRIDGE BIOPHARMA® is a registered trademark of the Strongbridge Biopharma plc. companies, which include Strongbridge Dublin Limited and Strongbridge U.S. Inc.
KEVEYIS® is a registered trademark licensed exclusively in the U.S. to Strongbridge Biopharma plc.
MLR-0010 V15 01/2019

  • Ireland Address:
    Suite 206, Fitzwilliam Hall
    Fitzwilliam Place, Dublin 2, D02 T292
    Ireland
  • U.S. Address:
    900 Northbrook Drive, Suite 200
    Trevose, PA 19053
    United States

Phone: +1 610-254-9200
[email protected]

Privacy Statement
Compliance Program